Interventional and synthetic therapy of advanced hepatocellular carcinoma  

晚期肝癌介入治疗综合措施的探讨(英文)

作　　者：曹喜才[1] 贺能树[1] 孙建中[1] 王松[1] 吉训明[1] 范海伦[1] 王金胜[1] 张长林[1] 杨建国[1] 吕提文[1] 李建华[1] 张国欣[1] 

机构地区：[1]天津医科大学总医院放射科,天津300052

出　　处：《Chinese Medical Journal》2002年第12期1883-1885,155-156,共3页中华医学杂志（英文版）

摘　　要：OBJECTIVE: To evaluate the clinical efficacy of interventional therapy in the treatment of hepatocellular carcinoma (HCC). METHODS: Thirty-three patients with HCC were synthetically treated by systematic measures. Among them, percutaneous port-catheter system (PCS) implantation via the femoral artery was performed in 21 cases. Patients with haemorrhage were treated with prothrombin complex concentrate and fibroraas, and patients with hepatic encephalopathy by branched-chain amino acids and arginine. RESULTS: All indwelling catheters of PCS were patent and no catheter tip dislocations were observed. Of 33 patients with advanced HCC, the mean survival rate was 20.1 months and 12 (36%) patients survived more than 2 years. CONCLUSION: Patients with advanced HCC were treated by synthetic measures. Survival was prolonged, quality of life was improved significantly, and the effectiveness of interventional therapy was further improved.目的　探讨晚期肝癌介入治疗综合措施 ,进一步提高临床疗效。方法　对 33例肝癌介入治疗晚期综合症状采取一系列治疗措施。 2 1例行经皮股动脉药盒导管系统 (PCS)植入术 ;出血应用凝血酶原复合物 ;肝性脑病应用支链氨基酸和颈精氨酸等综合措施。结果　 2 1例PCS术后留置管全部保持通畅。 33例平均生存期 2 0 1个月 ,2年生存率为 36%。结论　对肝癌介入治疗晚期采取一系列综合措施可延长患者生存期 ,提高生存质量 ,是肝癌介入治疗上一个新台阶。

关 键 词：ADULT Aged Carcinoma  Hepatocellular Catheters  Indwelling FEMALE Humans Liver Neoplasms Male Middle Aged Survival Rate 

分 类 号：R735.7[医药卫生—肿瘤]